Content area
Full text
Excessive lung inflammation is a major factor in the morbidity associated with cystic fibrosis. Despite the lack of evidence of convincing benefit, 1 2 corticosteroids are being increasingly prescribed to children with cystic fibrosis to reduce this inflammation, whilst ibuprofen has also been advocated as a useful anti-inflammatory agent. We wished to ascertain current prescribing practice in the UK, so carried out a postal survey of all specialist cystic fibrosis centres treating children under 18 years of age.
Surveys were returned from all 31 centres that collectively care for around 3500 patients and the results are shown in fig 1 . Within centres, regular oral steroids were prescribed to a median (interquartile range, IQR) of...